Trial Details

Not Recruiting
Basic Information
Clinical ID c2975
Identifier JPRN-UMIN000019958
Trial Title Research for biomarkers of inflammatory bowel disease. - Investigation of the usefulness of LRG for evaluation of disease condition after adalimumab treatments - Investigation of the usefulness of LRG for evaluation of disease condition after adalimumab treatments
Trial URL Visit Original Page
Study Information
Study Results

Yes

Conditions Crohn's disease, ulcerative colitis
Interventions Patients with Crohn's disease or ulcerative colitis Adalimumab administration subcutaneously for 52 weeks using the recommended dosing regimens.
Participant Information
Sponsor Iwate Medical University Kochi Medical School Hospital Keio University School of Medicine
City -
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type Interventional
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date 2018-11-20